THERAPEUTIC ADVANCES IN GASTROENTEROLOGY[ta] - Search Results

Year	Number of Results
2008	18
2009	35
2010	33
2011	36
2012	36
2013	38
2014	27
2015	40
2016	105
2017	82
2018	70
2019	93
2020	125
2021	17

1

Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges.

Su S, Shen J, Zhu L, Qiu Y, He JS, Tan JY, Iacucci M, Ng SC, Ghosh S, Mao R, Liang J. Su S, et al. Therap Adv Gastroenterol. 2020 Jun 18;13:1756284820934626. doi: 10.1177/1756284820934626. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 32595762 Free PMC article. Review.

2

Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions.

Cangemi DJ, Lacy BE. Cangemi DJ, et al. Therap Adv Gastroenterol. 2019 Oct 4;12:1756284819878950. doi: 10.1177/1756284819878950. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31632456 Free PMC article. Review.

3

Insights into the role of cannabis in the management of inflammatory bowel disease.

Picardo S, Kaplan GG, Sharkey KA, Seow CH. Picardo S, et al. Therap Adv Gastroenterol. 2019 Sep 3;12:1756284819870977. doi: 10.1177/1756284819870977. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31523278 Free PMC article. Review.

4

The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?

Segal JP, Mak JWY, Mullish BH, Alexander JL, Ng SC, Marchesi JR. Segal JP, et al. Therap Adv Gastroenterol. 2020 Nov 24;13:1756284820974914. doi: 10.1177/1756284820974914. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 33281941 Free PMC article. Review.

5

Biologics and surgical outcomes in Crohn's disease: is there a direct relationship?

Quaresma AB, Yamamoto T, Kotze PG. Quaresma AB, et al. Therap Adv Gastroenterol. 2020 Jul 16;13:1756284820931738. doi: 10.1177/1756284820931738. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 32728389 Free PMC article. Review.

6

Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review.

Chey WD, Shah ED, DuPont HL. Chey WD, et al. Therap Adv Gastroenterol. 2020 Jan 23;13:1756284819897531. doi: 10.1177/1756284819897531. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 32047534 Free PMC article. Review.

7

New biologics and small molecules in inflammatory bowel disease: an update.

Sabino J, Verstockt B, Vermeire S, Ferrante M. Sabino J, et al. Therap Adv Gastroenterol. 2019 May 26;12:1756284819853208. doi: 10.1177/1756284819853208. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31205488 Free PMC article. Review.

8

Cholestatic liver diseases: new targets, new therapies.

Santiago P, Scheinberg AR, Levy C. Santiago P, et al. Therap Adv Gastroenterol. 2018 Aug 24;11:1756284818787400. doi: 10.1177/1756284818787400. eCollection 2018. Therap Adv Gastroenterol. 2018. PMID: 30159035 Free PMC article. Review.

9

Advances in immunotherapy for colorectal cancer: a review.

Golshani G, Zhang Y. Golshani G, et al. Therap Adv Gastroenterol. 2020 Jun 1;13:1756284820917527. doi: 10.1177/1756284820917527. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 32536977 Free PMC article. Review.

10

Potential neuro-immune therapeutic targets in irritable bowel syndrome.

Casado-Bedmar M, Keita ÅV. Casado-Bedmar M, et al. Therap Adv Gastroenterol. 2020 Apr 9;13:1756284820910630. doi: 10.1177/1756284820910630. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 32313554 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results